Here are 2 very different penny stocks. Should I buy them?

Our writer looks at two penny stocks with different characteristics. But when it comes to deciding which to buy, he arrives at the same conclusion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

British Pennies on a Pound Note

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There are two penny stocks I’ve been researching at opposite ends of the innovation spectrum.

One is a relatively new company at the cutting edge of international medical research. The other has been in business for 60 years, selling tiles from its large chain of UK stores.

However, each has recently caught my eye due to significant movements in their share prices.

Should I buy one, both, or neither of them?

An innovative approach

Shares in Angle (LSE:AGL) have increased 64% since the start of 2024.

The announcement of a “breakthrough” in trials for its cancer diagnostics tool have helped propel them higher.

In 70% of patients, the company’s technology found cancer mutations in cells that could not be identified from the DNA in the same blood.

There’s little point dwelling on the financial performance of the company as the investment case is built entirely around its future potential.

By 30 June 2023, the company had accumulated losses of £113m. Yet revenue for 2023 is expected to be only £2.2m.

On the plus side, it says it has sufficient cash to see it through until, at least, the first quarter of 2025.

Old-fashioned

By contrast, Topps Tiles (LSE:TPT) stock is down 8%, since 1 January.

Investors didn’t like the trading update that revealed sales for the 13 weeks to 30 December 2023, were 4% lower than a year earlier.

But the company has been growing steadily for several years.

It achieved its 2025 target of a 20% market share two years earlier than planned. It expects this to increase further in 2024.

And its shares are presently yielding a very attractive 7.9%. Each year, it plans to return 67% of earnings to shareholders.

However, rising costs caused its gross margin to fall from 54.8% during its 2022 financial year, to 53%, in 2023. This is something to keep an eye on.

Decision time

Although there are reasons to invest in both, I’m cautious about penny stocks.

For example, I don’t have sufficient expertise to know whether the products of innovative companies, like Angle, are going to be successful.

Its technical reports make for heavy reading.

And if I’m honest, I’d only be buying its shares on a ‘hunch’. That doesn’t feel like a sensible basis for making sound investment decisions.

Also, because what they’re doing is pushing boundaries, the timescales for bringing products to market can slip.

Ironically, with more ‘traditional’ businesses like Topps Tiles, it’s the lack of technological innovation that worries me.

‘Bricks and mortar’ retailing is tough, with the internet radically changing the way people shop.

And consumer tastes can change quickly. I’m not sure the company has the financial strength to cope with a sustained downturn.

Both Angle and Topps Tiles highlight my principal fear about penny stocks, namely, that they will run out of money. With small businesses, there’s an increased risk that any investment I make today will be diluted in the future.

Should either company need to raise funds, they will probably ask their shareholders to buy more shares, rather than increase their borrowings.

If I don’t want to participate in a rights issue, the value of my shareholding will fall. Joining in will require more cash.

As a risk-averse investor, I don’t want to have to face this dilemma.

James Beard has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »

Investing Articles

3 top Vanguard ETFs to consider for an ISA or SIPP in 2026

Edward Sheldon believes that these three Vanguard ETFs could be solid investments for a pension (SIPP) or investment account in…

Read more »

Investing Articles

5 growth stocks on Dr James Fox’s watchlist for 2026

Dr James Fox believes these UK and US growth stocks are worth considering as he looks to outperform the stock…

Read more »